Mineralys Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire•03/11/2026•16:05 ET
0
Key Highlights
- ➤Mineralys management to join three upcoming investor conference fireside chats
- ➤Guggenheim Healthcare Innovation Conference fireside chat scheduled for November 10, 2026
- ➤Stifel Healthcare Conference fireside chat scheduled for November 12, 2026
- ➤Evercore Healthcare Conference fireside chat scheduled for December 1, 2026
RADNOR, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, today announced that members of senior management will be participating in fireside chats at three upcoming investor conferences.
Guggenheim Healthcare Innovation Conference Date: Tuesday, November 10, 2026 Time: 2:30pm ET Format: Fireside Chat Webcast Link
Get started
Create a free account to read the full story.